1. ALLA AKTIER
  2. NYHETER
  3. SYNACT PHARMA

SynAct Pharma

Nyheter SynAct Pharma Nyheter alla bolag

Patrik Renblad is leaving SynAct Pharma and the search for a new CFO has been initiated

MARKN.

SynAct Pharma AB (publ) (“SynAct”) today announced that its Chief Financial Officer, Patrik Renblad has resigned and will move to a new assignment outside of the company. He will leave SynAct by the end of July, 2023, at the latest.

Patrik Renblad joined SynAct in 2021 and has during his tenure been instrumental in preparing the company for and taking the step to a listing of the share at Nasdaq Stockholm’s main market, coordinating the acquisition of TXP Pharma and two financing rounds, bringing in 230 mSEK in proceeds.

The process to recruit a new Chief Financial Officer has been initiated.

The information was submitted for publication, through the agency of the contact persons set out below, at 8.00 am CET, February 1, 2023.

For further information about SynAct Pharma AB, please contact:
Jeppe Øvlesen
CEO, SynAct Pharma AB
Phone: +45 28 44 75 67
Mail: joo@synactpharma.com              
 
Patrik Renblad
CFO, SynAct Pharma AB 
Phone: +46 707 47 97 68 
Mail: par@synactpharma.com

About SynAct Pharma AB
SynAct Pharma AB (publ) (Nasdaq Stockholm: SYNACT) conducts research and development in inflammatory diseases. The company has a platform technology based on a new class of drug candidates aimed at acute deterioration in chronic inflammatory diseases with the primary purpose of stimulating natural healing mechanisms. For more information: www.synactpharma.com. 

Attachments
Patrik Renblad is leaving SynAct Pharma and the search for a new CFO has been initiated

Datum 2023-02-01, kl 08:00
Källa MFN
Bifogade filer
Patrik Renblad is leaving SynAct Pharma and the search for a new CFO has been initiated
Affiliate
Ungdomsdeal - 200 kr ! Just nu får alla nya kunder mellan 18 och 25 år 200 kr gratis när man skapar konto på Nordnet, insatt i fonden Nordnet One Balanserad. Bra läge att testa Nordnet!
Investeringar i värdepapper och fonder innebär alltid en risk och det är inte säkert att du får tillbaka det investerade kapitalet